Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on August 1, 2025
Home Potassium Monitoring Devices Market to Surge to $478.68 Million by 2034, Expanding at 18.40% CAGR
EIN Presswire
·
August 1, 2025
global home potassium monitoring devices market was valued at approximately USD 88.42 million in 2024 and is expected to reach around USD 478.68 million by 2034 PUNE, MAHARASHTRA, INDIA, August 1, 2025 /EINPresswire.com/ -- Executive Summary: The …
Spectruth DAO Pioneers Real-World Solutions for PTSD Diagnosis/Healing With Decentralized Science and Precision Medicine
EIN Presswire
·
August 1, 2025
KYIV, KYIV OBLAST, KYRGYZSTAN, August 1, 2025 /EINPresswire.com/ -- Post-Traumatic Stress Disorder (PTSD) remains a devastating mental health crisis worldwide, impacting millions of people with profound social and economic consequences. Studies estimate …
Health 2.0 Conference Highlights Cross-Sector Response To Healthcare Scam Surge
EIN Presswire
·
August 1, 2025
Global healthcare stakeholders unite in Dubai at the Health 2.0 Conference to confront rising threats of medical fraud, fake reviews, and digital spam. DUBAI, UNITED ARAB EMIRATES, August 1, 2025 /EINPresswire.com/ -- As digital scam tactics and …
Spectruth DAO Launches Ambassador Program to Empower Community and Accelerate Mental Health Innovation
EIN Presswire
·
August 1, 2025
New initiative offers passionate supporters a chance to earn $SPEC tokens, gain exclusive access, and help shape the future of decentralized PTSD care KYIV, KYIV OBLAST, UKRAINE, August 1, 2025 /EINPresswire.com/ -- Spectruth DAO, a pioneering …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …
Spectruth DAO Breaks New Ground: Deposit Placed for First Mobile PTSD and Trauma Diagnostic Vehicle
EIN Presswire
·
August 1, 2025
Advancing decentralized, data-driven mental health care with cutting-edge mobile technology KYIV, KYIV OBLAST, UKRAINE, August 1, 2025 /EINPresswire.com/ -- Spectruth DAO, a pioneering decentralized autonomous organization dedicated to precision healing …
Thailand LAB INTERNATIONAL 2025 Unlocks Laboratory and Innovation for Thailand’s Future Economy
EIN Presswire
·
August 1, 2025
Held 3–5 Sept 2025 in Bangkok, the event brings 500+ global brands, 160+ speakers, and groundbreaking innovations in biotech, diagnostics, and food-tech. BITEC BANGNA, BANGKOK, THAILAND, August 1, 2025 /EINPresswire.com/ -- Thailand reaffirms its …
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS
GlobeNewswire
·
August 1, 2025
IRVINE, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests addressing unmet clinical needs, is excited to announce that its SmartVascular Dx™ (SVDx) test, …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Sirona Biochem Update to Shareholders on Financial Status and Operations
GlobeNewswire
·
August 1, 2025
VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (“Sirona”) wishes to provide shareholders with a critical update on the company’s financial position and recent corporate developments. The …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
WALTHAM, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Peacemeal by Liying Peng Wins Bronze in A' Mobile Technology Awards
EIN Presswire
·
August 1, 2025
Innovative Wellness App Recognized for User-Centered Design and Compassionate Approach to Weight Gain Support COMO, CO, ITALY, August 1, 2025 /EINPresswire.com/ -- The A' Design Award, a highly prestigious and well-recognized award in the field of …
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“ImageneBio”), a clinical stage biotechnology company dedicated to developing treatments for immunological/autoimmune and inflammatory (“I…
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent …
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
GlobeNewswire
·
August 1, 2025
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR …
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2025
GlobeNewswire
·
August 1, 2025
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext Paris Code ISIN : FR 0010417345 …
NuCana Announces ADS Ratio Change
GlobeNewswire
·
August 1, 2025
EDINBURGH, United Kingdom, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announces that it will implement the Company’s previously disclosed plans to change the ratio of its American Depository Shares (“ADSs”) to …
Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025
GlobeNewswire
·
August 1, 2025
PETACH TIKVA, Israel, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly-hired employees options to purchase an …